Success Stories: Thanks to Our Team’s Case Preparation and PP Upgrade, NIW Approval Obtained in 8 Days for a Research Data Analyst in Medical Biology from Nepal

Client’s Testimonial:

“Thank you for your help and guidance.”

On March 14^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Data Analyst in the Field of Medical Biology (Approval Notice).

General Field: Medical Biology

Position at the Time of Case Filing: Research Data Analyst

Country of Origin: Nepal

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 14^th, 2023

Processing Time: 8 days (Premium Processing Requested)

Case Summary:

Some of the key factors in the EB2-NIW (National Interest Waiver) approval of a research data analyst in medical biology from Nepal are:

As an expert in medical biology, his proposed endeavor was to continue his research using statistical methodologies to design, conduct, and analyze clinical research studies. He wanted to determine better treatment approaches for health disorders, identify adverse health effects of current or past health practices, and find associations and interactions between exposure and existing health treatments.
His research advancing his proposed endeavor is of great importance because it addresses key medical issues of antibiotic resistance and kidney disease. He has developed methods to improve existing antibiotics’ ability to overcome the resistance of bacteria.
This research endeavor also has broad implications for the United States where growing antibacterial resistance naturally affects the ability of the United States medical community to treat many common illnesses. He has both improved the ability of antibiotics to overcome antibiotics resistance and identified ways to improve the treatment of patients with kidney disease.
Due to its clear national importance, his work has been supported with funding from the Veterans Affairs Health Services Research and Development Service.
His research has also resulted in 4 peer-reviewed journal articles (3 of them first-authored) and 1 peer-reviewed co-authored book chapter and these publications have been cited a total of 80 times according to Google Scholar.
Many other researchers have been significantly influenced in their own work by his prior findings which illustrate the fact that his case is of great value to the United States.
Additionally, he has pursued research directly related to his proposed endeavor of using statistical methodologies to design, conduct, and analyze clinical research studies for 10 years.
His work has been recognized by other experienced researchers who wrote letters recommending his work for the U.S. One of them stated:

“The world is in dire need of new antibiotics or new approaches to treating bacterial infections. [The client], a renowned medical biologist, has conducted highly significant investigations of this problem through a systematic study of antibiotics and bacteria. His research has uncovered new findings regarding the efficacy of existing antibiotics and methods for enhancing their efficacy in treating antibiotic-resistant bacteria.”

These factors went a long way in winning him the approval of the adjudication committee. What is more, his case got expedited approval in just 8 days of application. This was made possible by the premium processing upgrade and our teamwork.

We wish our client all the best in his future endeavors and look forward to seeing his work benefit the U.S. in the future as well.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.